Abstract:Abstract Funding Acknowledgements Swedish Heart-Lung Foundation, Swedish Society of Medicine, Swedish Heart Association, Skåne University Hospital, Region Skåne, and Lund University Background Ebstein’s anomaly (EA) is due to failed delamination of the tricuspid valve (TV) causing TV regurgitation (TR) and right ventricular (RV) dilatation, reduced exercise capacity and survival. TV repair/replacement (TVR) aims to reduce morbidity and mortality by reducing regurgitation and RV dilatation. Exercise capacity measured by predicted peak oxygen uptake (VO2%) and ventilatory expiratory slope (VE/CO2) is often impaired in EA and both are markers for mortality in adult congenital heart disease. Cardiovascular magnetic resonance (CMR) derived risk factors for adverse events (MACE) in unrepaired EA include reduced biventricular ejection fraction (EF) and low cardiac index. Whether and how these markers are modulated by TVR requires study. Purpose We aimed to assess whether TVR modulates known markers of exercise intolerance and CMR risk factors for MACE in EA. Methods Thirty-six consecutive EA adult (age≥16 years) patients (age at operation 37.4 ± 15.4 years, 13/12 ASD/PFO closures, 64% women) who underwent TV repair/replacement (15/21) between 2004-2014 and had pre-TVR CMR were retrospectively included. Twenty-four had CMR (in median 1.7 years) after TVR. Thirty-four had cardiopulmonary exercise test with VO2% and VE/CO2 prior to TVR, 23 one year and 17 five years after TVR. For CMR biventricular assessment, delineations were performed in short-axis cine stacks. Cardiac index was computed from velocity encoded phase contrast images from aortic flow. All volumes were indexed to body surface area. TR was graded none to severe (0-3). Results Thirty patients were in NYHA class ≥2 pre-TVR, 10 at 1-year and 8 at 5-year post-TVR (Figure 1). Compared to pre-TVR, VO2% continued to increase 5 years post-TVR (60 ± 16% vs 72 ± 14%, p = 0.002), but was not significantly increased at 1-year post-TVR (69 ± 19%, p = 0.06). For VE/CO2, pre-TVR values (40 ± 15) were increased compared to 1-year post-TVR (33 ± 6, p = 0.02) but without further amelioration after 5 years (33 ± 6). Cardiac index increased (2.4 ± 0.7 vs 2.8 ± 0.5/min/m2, p = 0.02). However, RVEF decreased (52 ± 7 vs 46 ± 9%, p = 0.003) and LVEF remained unchanged (68 ± 8 vs 67 ± 8%, p = 0.3) after TVR. As expected, surgery reduced TR grade (median 3 vs 1.5), RVEDVi (174 ± 51 vs 109 ± 22ml/m2) and RV/LV ratio (2.9 ± 1.1 vs 1.7 ± 0.3, all p < 0.0001). Conclusions TV surgery for Ebstein’s anomaly clearly modulates known risk factors for adverse outcome and was associated with improved subjective and objective exercise tolerance early and mid-term after intervention. This may be due to the concurrent increase in cardiac index demonstrated by CMR and secondary to augmented LV end diastolic volume at a stable LVEF. These findings are suggestive of improved future freedom from MACE. But this needs testing including the degree to which the RVEF decline seen post-TVR mitigates potential benefits beyond symptoms. The improvement in VO2% continued for 5 years which indicates clinical improvement after TVR continues past the first year. Abstract 1162 Figure 1

Abstract 12474: Left Atrial Function and Clinical Outcomes After Tricuspid Valve Surgery for Atrial Functional Tricuspid Regurgitation

Association of longitudinal left atrial strain with mortality after tricuspid valve surgery

Abstract 14268: Prognostic Value of Clinical and Echocardiographic Factors in Atrial Functional Tricuspid Regurgitation

Abstract 9559: Isolated Functional Tricuspid Regurgitation: Importance of Atrial Fibrillation and Right Atrial Remodeling and Prognostic Significance

Isolated Tricuspid Valve Surgery for Functional Tricuspid Regurgitation

Abstract 11678: Tricuspid Valve Repair Versus Replacement for Very Severe Functional Tricuspid Regurgitation

The role of left atrial strain in patients with functional tricuspid regurgitation before and after annuloplasty: a long-term follow-up study

Atrial Functional Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement

Evolution of Tricuspid Regurgitation after Mitral Valve Surgery for Patients with Moderate-Or-Less Functional Tricuspid Regurgitation

Atrial Functional Tricuspid Regurgitation: Novel Definition and Impact on Prognosis

Right ventricular remodeling and clinical outcomes following transcatheter tricuspid valve intervention

Concomitant tricuspid valve surgery in patients with significant tricuspid regurgitation undergoing left ventricular assist device implantation: A systematic review and meta‐analysis

Early and mid-term outcomes of tricuspid valve surgery in patients with functional tricuspid regurgitation induced by atrial fibrillation

Abstract 15424: Tricuspid Valve Geometry and Right Heart Remodeling: Insights Into the Mechanism of Atrial Functional Tricuspid Regurgitation

Late follow-up for a randomized trial of surgical treatment of tricuspid valve regurgitation in patients undergoing left ventricular assist device implantation

P3655Right Ventricular Volume Off-Loading Following Atrial Septal Defect Closure or Pulmonary Valve Replacement: Impact on Tricuspid Regurgitation and Mid-Term Remodeling

Tricuspid Regurgitation Severity after Atrial Septal Defect Closure or Pulmonic Valve Replacement.

Tricuspid regurgitation in atrial fibrillation: correlation to left atrial myopathy and improvement post ablation

Impact of catheter ablation on functional tricuspid regurgitation in patients with atrial fibrillation

1162 Improved Exercise Tolerance and Cardiac Index at Mid-Term Follow Up after Tricuspid Valve Surgery of Ebsteins Anomaly

Prevalence and Prognostic Importance of Massive Tricuspid Regurgitation in Patients Undergoing Tricuspid Annuloplasty With Concomitant Left-Sided Valve Surgery: A Study on Rheumatic Valvular Heart Disease